15. 宫颈腺癌5年远处失败率较鳞癌高Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage 1B cervical carcinoma. Gynecol Oncol 1995;59:38–44.
16. 辅助放疗后宫颈腺癌的无进展生存率低于鳞癌
辅助放化疗后无进展生存率腺癌与鳞癌相当Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrentchemotherapy and pelvic radiation therapy compared with pelvic radiationtherapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 2000;18:1606–13.
18. Pentl AA,lymphatic system of the female genitalia.The morphologic basis of oncolgic diagnosis and therapy [J].Major probl obstet gynecol,1971,2:1-223宫颈间质浆膜下淋巴管宫旁淋巴结盆腔淋巴结腹主动脉旁淋巴结
32. RTOG宫颈癌及子宫内膜癌术后放疗靶区的共识William SJ,Loren KM,Penny A,et al.consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer[J]int. J. Radiat. Oncol Biol Phys,2008,71(2):428-434靶区定义髂总淋巴结L4L5椎间隙下7MM到髂总分叉为髂内外血管髂外淋巴结髂总分叉到股骨头上缘即股动脉髂内淋巴结髂总分叉到阴道切端所在宫旁组织水平阴道上端阴道切端及切端往下3cm宫旁组织阴道切端到闭孔内肌内侧或两侧的坐骨支骶前淋巴结S1~S2前缘